| Item Type | Name |
|
Academic Article
|
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study.
|
|
Academic Article
|
Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE).
|
|
Academic Article
|
Natural history of concentric left ventricular geometry in community-dwelling older adults without heart failure during seven years of follow-up.
|
|
Academic Article
|
Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
|
|
Academic Article
|
New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function.
|
|
Academic Article
|
Membrane-associated matrix proteolysis and heart failure.
|
|
Academic Article
|
Diastolic heart failure. Diagnosis, prognosis, treatment.
|
|
Academic Article
|
Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.
|
|
Academic Article
|
Severe left ventricular hypertrophy 1 year after transplant predicts mortality in cardiac transplant recipients.
|
|
Academic Article
|
Chronic ambulatory intracardiac pressures and future heart failure events.
|
|
Academic Article
|
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
|
|
Academic Article
|
Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.
|
|
Academic Article
|
Chronic mitral regurgitation: predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress.
|
|
Concept
|
Prognosis
|
|
Academic Article
|
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
|
|
Academic Article
|
Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction.
|
|
Academic Article
|
Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).
|
|
Academic Article
|
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.
|
|
Academic Article
|
The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern.
|
|
Academic Article
|
Impaired left atrial function in heart failure with preserved ejection fraction.
|
|
Academic Article
|
Adverse left ventricular remodeling in community-dwelling older adults predicts incident heart failure and mortality.
|
|
Academic Article
|
History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction.
|
|
Academic Article
|
Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST).
|
|
Academic Article
|
Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
|
|
Academic Article
|
The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
|
|
Academic Article
|
Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
|
|
Academic Article
|
Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF.
|
|
Academic Article
|
Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial.
|
|
Academic Article
|
The risk of death associated with proteinuria in heart failure is restricted to patients with an elevated blood urea nitrogen to creatinine ratio.
|
|
Academic Article
|
Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
|
|
Academic Article
|
Influence of Sacubitril/Valsartan (LCZ696)?on?30-Day Readmission After Heart Failure Hospitalization.
|
|
Academic Article
|
Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.
|
|
Academic Article
|
Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
|
|
Academic Article
|
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
|
|
Academic Article
|
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
|
|
Academic Article
|
Type of Atrial Fibrillation and Outcomes in?Patients With Heart Failure and Reduced?Ejection?Fraction.
|
|
Academic Article
|
Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure).
|
|
Academic Article
|
Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
|
|
Academic Article
|
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
|
|
Academic Article
|
Differential Impact of Heart Failure With?Reduced Ejection Fraction on?Men?and?Women.
|
|
Academic Article
|
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
|
|
Academic Article
|
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
|
|
Academic Article
|
Should We Test for Diastolic Dysfunction? How and How Often?
|
|
Academic Article
|
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
|
|
Academic Article
|
Relation of Lymphangiogenic Factor Vascular Endothelial Growth Factor-D to Elevated Pulmonary Artery Wedge Pressure.
|
|
Academic Article
|
Age-Related Characteristics and Outcomes of Patients With Heart?Failure With Preserved Ejection Fraction.
|
|
Academic Article
|
Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
|
|
Academic Article
|
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.
|
|
Academic Article
|
Echocardiographic Features of Patients?With Heart?Failure and Preserved?Left Ventricular Ejection Fraction.
|
|
Academic Article
|
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction.
|
|
Academic Article
|
Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction.
|
|
Academic Article
|
Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure.
|
|
Academic Article
|
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart?Failure With Preserved Ejection Fraction.
|
|
Academic Article
|
Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction.
|
|
Academic Article
|
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
|
|
Academic Article
|
Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart?Failure Position Paper.
|
|
Academic Article
|
Covariate adjusted reanalysis of the I-Preserve trial.
|
|
Academic Article
|
Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE.
|
|
Academic Article
|
Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real-world population.
|
|
Academic Article
|
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
|
|
Academic Article
|
Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials.
|
|
Academic Article
|
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE.
|
|
Academic Article
|
Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction.
|
|
Academic Article
|
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction.
|
|
Academic Article
|
Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.
|
|
Academic Article
|
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
|
|
Academic Article
|
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
|
|
Academic Article
|
Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial.
|